AAIC 2021 - Epidemiological impact of Alzheimer´s disease and other dementias in the Spanish-Portuguese border region.
Montserrat Alonso-Sardón, MD, PhD1; María Antonia Martín-Delgado, PhD2; Raixa Noemí Pérez-Martín2; Eva González Ortega, PhD1 and NEUROQUALYFAM group, (1)University of Salamanca, Salamanca, Spain, (2)Regional Health Management of Castilla y León, Valladolid, Spain
Background:
Dementia has reached epidemic proportions and become a huge Public Health problem. Alzheimer’s disease (AD) is the most common type of dementia. In Spain, more than 800,000 people suffer from AD (Spanish Society of Neurology-SEN). Age is the main risk marker for...
Dr. Perlmutter returns to the Dr. Gundry Podcast to discuss the new data that's reshaping Alzheimer's disease treatment. One in nine Americans over age...
Alzheimer's disease has increased 134% since 2000, while cardiovascular disease—the #1 killer of men and women—has decreased by nearly 4%. So why do we...
Video presentation on research paper "TATC: Predicting Alzheimer’s Disease with Actigraphy Data" by Asad Bin Imtiaz (aimtiaz2) for CS598 Data Mining Capstone course Spring...
Neurologist and bestselling author Dr. David Perlmutter, author of Brain Defenders, explains how metabolism, inflammation, microglia, sleep, exercise, diet, and environmental exposures may shape...